PROQR THERAPEUTICS N.V. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.86 USD | -2.11% |
|
-19.13% | -6.06% |
Chart calendar ProQR Therapeutics N.V.
a70d1b2a09e0004fc75d3c1e27a94f.ffrdCqEAC903KoXD1ddGOo1FW9QztgdwKGf-gVPwy-k.K7-VSMhQXpxac_yN4O4FcsoAOZlK1EEZUQPOtgaXhawto49-zmF7nnZA4g~85cb97b48a62ff8d9bcdd60bd62d110a
Upcoming events on ProQR Therapeutics N.V.
Past events on ProQR Therapeutics N.V.
| 2024-03-13 07:00 am | Q4 2023 Earnings Release |
| 2023-11-07 07:00 am | Q3 2023 Earnings Release |
| 2023-10-02 09:30 am | Chardan Genetic Medicines Conference - Panel |
| 2023-09-11 07:00 am | H.C. Wainwright Global Investment Conference |
| 2023-08-03 07:00 am | Q2 2023 Earnings Release |
| 2023-07-12 04:00 pm | RNA Editing Summit |
| 2023-06-20 | RNA Therapeutics Conference |
| 2023-05-31 | Dutch Antisense Therapeutics Symposium |
| 2023-05-30 05:15 pm | Stifel Tailoring Genes Genetic Medicines Day |
| 2023-05-17 10:00 am | Annual General Meeting |
| 2023-05-16 07:00 am | Q1 2023 Earnings Release |
| 2023-05-09 12:30 pm | Oligonucleotide and Peptide Therapeutics Conference |
| 2023-04-25 | Kempen Lifesciences Conference |
| 2023-03-29 10:00 am | R&D Day |
| 2023-03-28 | Q4 2022 Earnings Release |
| 2023-03-22 | RNA Editing Gordon Research Conference |
| 2023-03-16 09:35 am | RNA Leaders Europe Congress |
| 2023-03-14 10:05 am | Oligonucleotide and Precision Therapeutics Congress - Panel Oligo Therapeutics Discovery and Deliver |
| 2023-03-14 09:35 am | Oligonucleotide and Precision Therapeutics Congress |
| 2022-11-18 08:30 am | Oligonucleotide and Peptide Therapeutics EUROPE conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 2,10 2,26 -6.86% | 11,6 10,9 5.91% | 2,71 5,69 -52.35% | 5,20 15,2 -65.74% | 10,4 19,5 -46.65% | 20,8 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -62,1 -63,7 2.62% | -67,4 -71,2 5.39% | -32,0 -38,7 17.11% | -57,1 |
|
EBIT Million USD | Released Forecast Spread | -62,5 -61,6 -1.38% | -51,8 -38,3 -35.35% | -64,7 -63,9 -1.26% | -70,1 -71,8 2.37% | -34,8 -23,7 -46.71% | -40,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -61,6 -60,4 -1.95% | -56,8 -53,7 -5.82% | -69,6 -67,9 -2.58% | -70,2 -71,1 1.34% | -30,4 -14,6 -107.53% | -32,3 |
|
Net income Million USD | Released Forecast Spread | -61,4 -60,4 -1.69% | -56,9 -53,7 -5.99% | -69,7 -67,8 -2.81% | -70,5 -70,3 -0.3% | -30,7 -19,1 -60.86% | -39,0 |
|
EPS USD | Released Forecast Spread | -1,50 -1,51 0.48% | -1,14 -1,08 -5.42% | -1,09 -1,01 -7.31% | -0,99 -0,98 -0.63% | -0,38 -0,27 -43.34% | -0,45 |
| Announcement Date | 26/02/20 | 25/02/21 | 24/02/22 | 29/03/23 | 13/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,50 0,86 -41.35% | 1,40 0,88 58.51% | 1,15 0,95 21.4% | 1,04 0,86 19.98% | 1,42 1,00 41.91% | 0,76 1,43 -47.03% | 1,36 1,32 3.14% | 1,47 3,65 -59.65% | 6,79 15,9 -57.33% | 4,28 | 4,28 | 4,28 | 7,02 |
|
EBITDA Million USD | Released Forecast Spread | -6,05 -8,89 31.93% | -13,2 | -13,9 | -14,6 | -15,3 | ||||||||
|
EBIT Million USD | Released Forecast Spread | -19,6 -17,3 -13.43% | -17,8 -18,0 1.18% | -16,1 -17,3 7.02% | -19,8 -15,0 -31.85% | -13,4 -16,1 16.95% | -10,2 -10,6 3.59% | -9,64 -9,51 -1.28% | -7,94 -6,62 -19.89% | -6,84 4,83 -241.82% | -9,91 | -10,4 | -10,9 | -6,22 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -20,6 -18,1 -14.1% | -15,2 -19,0 20.23% | -15,0 -18,5 19.12% | -24,4 -15,8 -54.96% | -12,3 -15,0 17.62% | -9,63 -9,36 -2.82% | -8,77 -9,61 8.78% | -5,87 -6,45 9.05% | -5,98 9,90 -160.4% | -8,33 | -8,80 | -9,22 | -6,03 |
|
Net income Million USD | Released Forecast Spread | -20,6 -18,0 -14.33% | -15,2 -19,0 20.08% | -15,2 -18,5 17.82% | -24,5 -10,3 -138.08% | -12,3 -14,3 13.63% | -9,71 -9,36 -3.72% | -8,74 -9,61 9.08% | -6,13 -6,55 6.33% | -5,99 5,48 -209.31% | -9,72 | -10,5 | -10,6 | -8,26 |
|
EPS USD | Released Forecast Spread | -0,29 -0,25 -18.69% | -0,21 -0,25 16.29% | -0,21 -0,23 7.96% | -0,34 -0,22 -58.79% | -0,17 -0,19 9.96% | -0,12 -0,13 7.53% | -0,11 -0,12 10.85% | -0,08 -0,09 14.24% | -0,08 0,03 -319.63% | -0,11 | -0,12 | -0,12 | -0,10 |
| Announcement Date | 24/02/22 | 05/05/22 | 04/08/22 | 09/11/22 | 29/03/23 | 16/05/23 | 03/08/23 | 07/11/23 | 13/03/24 | - | - | - | - |
More events
Past sector events for ProQR Therapeutics N.V.
| 2024-04-17 | BEIJING KAWIN TECHNOLOGY SHARE-HOLDING CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-04-17 | JIANGSU YAHONG MEDITECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-12 | SINOCELLTECH GROUP LIMITED: Q4 2023 Earnings Release |
| 2024-04-10 07:00 am | NURIX THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-04-08 | MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-02 03:06 am | TAIMED BIOLOGICS INC.: March 2024 Sales and Revenue Release |
| 2024-03-31 | PEPTRON, INC.: Q4 2023 Earnings Release (Projected) |
| 2024-03-31 | BIONEER CORPORATION: Q4 2023 Earnings Release (Projected) |
| 2024-03-29 08:30 am | INNOCARE PHARMA LIMITED: Q4 2023 Earnings Release |
| 2024-03-28 | BIO-THERA SOLUTIONS, LTD.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PRQR Stock
- Calendar ProQR Therapeutics N.V.
